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Abstract
Background: The liver function test (LFT) is among the most commonly used clinical investigations to assess hepatic
function, severity of liver diseases and the effect of therapies, as well as to detect drug-induced liver injury (DILI).
Aims: To determine the relative contribution of genetic and environmental factors as well as test and quantify the effects of
sex, age, BMI and alcohol consumption to variation in liver function test proteins - including alanine amino transaminase
(ALT), Albumin, gamma glutamyl transpeptidase (GGT), total bilirubin, total protein, total globulin, aspartate transaminase
(AST), and alkaline phosphotase (ALP) - using the classical twin model.
Methods: Blood samples were collected from a total of 5380 twin pairs from the TwinsUK registry. We measured the
expression levels of major proteins associated with the LFT, calculated BMI from measured weight and height and
questionnaires were completed for alcohol consumption by the twins. The relative contribution of genetic and
environmental factors to variation in the LFT proteins was assessed and quantified using a variance components model
fitting approach.
Results: Our results show that (1) variation in all the LFTs has a significant heritable basis (h
2 ranging from 20% to 77%); (2)
other than GGT, the LFTs are all affected to some extent by common environmental factors (c
2 ranging from 24% to 54%);
and (3) a small but significant proportion of the variation in the LFTs was due to confounding effects of age, sex, BMI, and
alcohol use.
Conclusions: Variation in the LFT proteins is under significant genetic and common environmental control although sex,
alcohol use, age and BMI also contribute significantly to inter-individual variation in the LFT proteins. Understanding the
underlying genetic contribution of liver function tests may help the interpretation of their results and explain wide variation
among individuals.
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Introduction
The liver function test (LFT) is a routinely ordered clinical
investigation used to assess hepatic function, disease severity [1–5],
and to evaluate response to treatment by measuring the levels of
various biomarkers (proteins) in the blood. These proteins reflect
different aspects of a normal functioning liver [6–8]. For example,
normal bilirubin (BILIRB) levels reflect adequate excretion of anions,
normal alanine amino transaminase (ALT) or aspartate transaminase
(AST) levels indicate hepatocellular integrity, and BILIRB or alkaline
phosphotase (ALP) levels provide insights into adequate formation
and flow of bile and albumin for protein synthesis.
In the clinic, LFT results are compared to and interpreted
according to reference charts containing internationally accept-
ed normal-levels for these proteins. However many patients are
investigated for having levels outside the normal range without
any obvious pathology or responsible factor being detected. The
most common biomarkers that are routinely measured as part
of the LFT include proteins which are specifically produced by
the liver – such as ALT and albumin (ALB) – as well as those
that are more ubiquitously produced, for example AST, which
is also produced by red blood cells and cardiac/ skeletal
muscles, and ALP which is also produced in bones and
kidneys.
PLoS ONE | www.plosone.org 1 February 2009 | Volume 4 | Issue 2 | e4435At the population level, previous studies have shown that some
of the LFT proteins are highly variable, affected by various
epidemiological factors including body mass index (BMI) [9,10],
alcohol consumption [11,12], and age [10,13,14], and that at least
some of these proteins are also influenced to some degrees by
genetic factors [11,15].
Twin studies provide one of the best epidemiological designs to
gain insights into the contribution of genetic and environmental
factors to population variation in clinical or evolutionary traits.
Here, we use the classical twin design to investigate the relative
contributions of genetic and environmental factors to variation in
the most common liver biomarkers including alanine amino
transaminase (ALT), albumin (ALB), gamma glutamyl transpep-
tidase (GGT), total bilirubin (TBILIRB), total protein (TPROT),
total globulin (TGLOB), aspartate transaminase (AST) and
alkaline phosphotase (ALP). Furthermore, we directly test for the
effect of age, sex, BMI, and alcohol use on variation in the LFT
proteins.
Materials and Methods
Ethics Statement
The study was approved by St. Thomas’ Hospital Research
Ethics Committee (EC96/439 Twins UK) and all participants
provided written informed consent.
Subjects and Questionnaire
A total of 5380 twins, comprising of 1804 DZ pairs and 886 MZ
pairs (female to male ratio of approximately 10:1), from the
TwinsUK database at St. Thomas’ Hospital [16] with mean age of
47 (range, 18–81years) were included in our study. Fasting blood
samples were collected from all twins for biochemical assays of the
liver function proteins and weight and height were measured at the
visit (BMI was calculated as weight (kg)/height (m
2)). Summary
characteristics of the cohort and the measured proteins are
presented in Table 1. Alcohol consumption data was collected
from self-reported questionnaires. Questionnaire frequencies of
recalled intake of beer, wine, fortified wine and spirits were
converted into units of alcohol per week (with one unit equal to half
a pint of beer, one glass of wine, or one measure of spirits) [17].
Biochemical Assays
All assays were performed on a Synchron LX20 automated
multi channel analyzer (Beckman Coulter, Fulleton, CA). ALT
activity was measured by a kinetic rate method (within run
precision 4.3 and between run 4.6 at 20 iu/L). Serum albumin
concentration was measured by means of a bichromatic digital
endpoint methodology using bromcresol purple (BCP) reagent
(within run precision 0.2 and between run 1.3 at 48 g/L). GGT
activity was measured by an enzymatic rate method (within run
precision 3.5 and between run 5.3 at 86 iu/L). BILIRB was
measured by a timed endpoint Diazo method (within run precision
3.0 and between run 4.5). TPROT concentration was measured
by means of a rate biuret method (within run precision 0.7 and
between run 0.87 at 75 g/L). AST activity was measured by an
enzymatic rate method (within run precision 0.7 and between run
1.0 at 175 iu/L). ALP activity was measured by a kinetic rate
method using a 2-amino-2-methyl-1-propanol (AMP) buffer
(within run precision 1.8 and between run 2.1 at 150 iu/L).
Twin Studies
Twin studies are the optimum epidemiological design to study
and partition population variation of a trait into genetic and non-
genetic - shared and unique environmental - components. The
classical twin design assumes that monozygotic twins share 100%
of their genes and shared environment whereas dizygotic twins
share on average 50% of their genes and 100% of shared
environment. Thus any greater similarity between MZ as
compared to DZ twin pairs is attributed to genetic factors [18,19].
Statistical Analysis
All measures of liver function test proteins were recorded as
continuousvariables.However,manywerenotnormallydistributed
Table 1. Descriptive statistics of the raw data for female and male MZ and DZ twins including total number of individuals (n),
means and standard deviations (s.d.) for the liver function test proteins and the major covariates included in the study.
Protein Female Male
MZ DZ MZ DZ
n Mean (s.d.) n Mean (s.d.) n Mean (s.d.) n Mean (s.d.)
Age (18–81 yrs) 1660 48.54 (13.57) 3320 46.52 (11.88) 112 43.76 (15.90) 288 48.34 (13.38)
BMI 1291 24.69 (4.50) 3091 25.21 (4.69) 95 26.27 (4.11) 278 26.24 (3.59)
Alcohol Use 1331 5.37(7.40) 2553 5.37(7.14) 58 11.51(10.91) 141 12.46(15.86)
ALT 1654 24.45 (12.19) 3302 25.45 (12.97) 112 27.49 (21.62) 285 34.65 (16.71)
ALB 1652 42.31 (3.23) 3302 41.82 (3.04) 110 45.25 (3.27) 287 42.78 (3.01)
GGT 1081 25.35 (22.05) 3032 25.35 (21.96) 63 32.66 (16.46) 274 44.62 (39.13)
BILIRB 1492 8.58 (3.61) 3282 8.70 (3.65) 63 12.90 (4.83) 274 12.41 (4.88)
TPROT 1490 71.26 (4.64) 3258 70.86 (5.19) 63 72.27 (3.42) 275 71.34 (4.89)
TGLOB 1486 29.41 (3.43) 3242 29.08 (3.88) 63 28.65 (3.28) 275 28.76 (4.19)
AST 98 10.31 (4.60) 477 9.74 (4.18) - - - -
ALP 1497 67.58 (19.84) 3285 67.08 (20.30) 63 72.99 (17.62) 275 74.66 (18.02)
Note AST was not measured in male twins.
doi:10.1371/journal.pone.0004435.t001
Genetic Basis of LFT Proteins
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analyses; Total protein, GGT, TGLOB and ALP were log10
transformed, ALT, BILIRB, TPROT and AST were square root
transformed, and ALB was normally distributed. Covariates age,
BMI and alcohol consumption were all continuous variables as well.
Demographic differences between MZ and DZ twins were
assessed by comparing means, medians and standard deviations
(Table 1). We carried out logistic regression analyses - treating sex
and zygosity as the explanatory variables - to check if age, BMI,
and alcohol consumption as well as the levels of the LFT proteins
were significantly different between male/female twins and MZ/
DZ twins.
Ordinary least squares regression was used for analysis of
covariates, age, BMI and sex. For alcohol consumption, truncated
Gaussian regression was used to assess the independent contribu-
tion of alcohol consumption to variation of protein assay.
Relatedness between the twins was accounted for using the
‘‘cluster’’ option in STATA. All preliminary analyses were
performed using STATA 10 [20].
Path analysis and genetic model fitting of twin data
Standard methods of quantitative genetic analysis were used to
model latent genetic and environmental factors influencing sibling
covariance for MZ and DZ twins. Genetic model fitting (path
analysis) was used for the decomposition of the observed
phenotypic variance (P) into additive (A) & dominant (D) genetic
components and environmental components shared by both twins
(C) & unique to each twin (E). The latter also includes
measurement error. Dividing each of these components by the
total variance yields the different standardized components of
variance. For example the (narrow sense) heritability (h
2) can be
defined as the proportion of the total variance attributable to
additive genetic variation or h
2=A/P. The significance of the
variance components A, C, and D are assessed by comparing the
model fit between a full model and a nested model in which each
term is sequentially set to zero. Model fit is assessed using the
likelihood ratio test. The purpose of the model fitting procedure is
to explain the pattern of observed variances and covariances as
accurately as possible. Genetic modeling was carried out using the
computer package Mx, which has been specifically designed for
analysis of twin and family data [21].
The effects of significantly associated covariates on LFT
proteins, particularly age and BMI were removed by regressing
LFT phenotype upon the covariates and model fitting was then
performed using the residuals.
Results
The age range of twins in the study was 18–81 years. Table 1
summarizes the characteristics of this cohort including total
number of individuals (n), the mean (6s.d.) values of the LFT
proteins for MZ/DZ, male/female twins.
The mean and standard deviations of the LFT proteins, BMI,
alcohol consumption, and age range for the MZ/DZ twin
populations within each sex group were comparable (p.0.05).
Significant differences by zygosity were noted for ALT in the male
twin cohort (p,10
24), although explicitly modeling the different
MZ/DZ means and variances did not qualitatively affect the
results in this case (data not shown).
Sex effects on the LFT enzymes
Age was comparable between male and female twin pairs
(x
2=0.04, p,0.83). As expected we observed a significant
difference in BMI (x
2=21.29, p,10
25) and alcohol consumption
(x
2=69.39, p,10
24) between the male and female twins. Overall,
male twins had a higher BMI and consumed significantly more
alcohol than female twins.
Except for TPROT and TGLOB, significant differences
between the sex groups was observed for all other LFT proteins
(p,1610
24) with the proportion of variability explained (R
2)
ranging from 1% in the case of ALP to 6% for GGT and BILIR
(Table 2); Note that AST was not measured in males.
Relationship between age, BMI, alcohol consumption,
and the LFT enzymes
As the mean and range of age was comparable across the male/
female sex strata we report results from pooled analyses (Table 3).
Age was shown to have a small but significant effect on all the LFT
enzymes except ALB and AST in the full cohort (p,0.005, R
2
ranging from less than 1% to up to 3% in the case of ALP).
BMI was significantly associated with ALT and GGT, in both
the male and female twin cohort (p,10
24,R
2 ranging from 2%
for ALT in females to 11% for ALT in males), and ALB, BILIRB
and ALP in female twin cohort only (p,10
23,R
2 ranging from
less than 1% for BILIRB to 8.2% for ALP).
We also checked for the effect of alcohol consumption on
variation in the LFT proteins in males and females twin pairs
respectively. Alcohol consumption showed suggestive association
with the variation in ALB, GGT, TPROT and TGLOB in the
male twin cohort (p,0.04). In the female twin cohort alcohol
consumption was significantly associated with GGT, TGLOB and
ALP (p,0.002).
Path analysis and genetic model fitting of twin data
The results of genetic model fitting are shown in Table 4. For
ALT, ALB, BILIRB, TPROT, TGLOB, AST and ALP, the ACE
model – ascribing the total phenotypic variance to additive
genetic, common and unique environments – was the best fitting
model with narrow-sense heritabilities ranging from 15% in the
case of TPROT to 48% in the case of ALP. For GGT the best
fitting parsimonious model was AE model, with up to 77% of the
total variation accounted for by additive genetic factors.
Discussion
In this study we used the classical twin design to gain insight into
the relative contribution of genetic, environmental, as well as
confounding effects of sex, age, body mass index and relative
alcohol use to variation in the all major liver function test proteins.
Table 2. Results of the logistic regression analyses of sex on
liver function test proteins.
Sex
NF p R
2
ALT 5353 40.30 1610
24 0.02
ALB 5351 46.22 1610
24 0.02
GGT 4450 152.5 1610
24 0.05
BILIRB 5111 158.8 1610
24 0.06
TPROT 5086 2.73 0.1 –
TGLOB 5066 2.94 0.1 –
AST –– – –
ALP 5120 59.47 1610
24 0.01
doi:10.1371/journal.pone.0004435.t002
Genetic Basis of LFT Proteins
PLoS ONE | www.plosone.org 3 February 2009 | Volume 4 | Issue 2 | e4435Our results show that (1) in agreement with previous studies,
variation in all the LFT proteins is highly variable; (2) a significant
proportion of the variation (up to 11%) in the LFTs was due to
confounding effects of age, sex, BMI, and alcohol use; (3) variation
in all LFTs has a significant heritable basis; and (4) other than
GGT, the LFTs are all affected to some extent by common
environmental factors.
Our results are in general agreement with previous cited studies
that have investigated the effects of age [22,13], sex [10,13,23],
BMI [13,14,22], and alcohol use [11,12] on variation in the liver
function test proteins. Age was shown to have a small but
significant effect on all the LFT enzymes except ALB and AST.
Except total protein and total globulin, we observed significant
sex differences with regards to variation in all the LFTs. For
instance, our results show that up to 6% of the variation in
bilirubin levels were due to sex. Furthermore, sex stratified analysis
showed that BMI contributes significantly and differentially to the
variation in many of the LFTs in our study. For example, up to
8% of the variation in ALP in females is due to variation in BMI
whereas BMI contributes insignificantly to ALP variation in males.
Moreover, although BMI is significantly associated to variation in
ALT in both males and females the explained proportion of the
variation in ALT by BMI is hugely different across sex groups; 2%
in females and 11% in males. Finally, alcohol consumption was
significantly associated with GGT, ALP, and total globulin in
females. Whilst in the males, we showed that there was a trend of
association with all the LFT proteins except ALT and ALP largely
due to the fact that the male cohort was approximately 10 fold
smaller than the female cohort. Interestingly, ALT, GGT and ALP
were found to be significantly affected by all four confounding
variable investigated - age, BMI, sex, alcohol use - highlighting the
present dilemma and difficulty faced by clinicians in interpreting
liver function test results.
Our study represents the largest and most extensive study to
investigate the influences of genes and environment on the major
LFT proteins. Our data shows that, quantitative variation in all
the major LFT proteins – corrected for the effects of age, sex,
BMI, and alcohol use – is under strong genetic control with
narrow-sense heritability ranging from 15 to 77%. Minor
differences were noted in the choice of the best fitting model for
ALT, ALB, BILIRB and ALP, when we carried out sex stratified
analyses, although point estimates of the A and C variance
components were very similar (data not shown). We have also
performed all our analysis by excluding male twins and our results
were unchanged.
Our study is in general agreement with two previous studies. A
small-scale study from the Danish twin registry consisting of 290
elderly twin pairs (age range between 73–102 years) were
measured for a subset of the LFTs by Bathum et al [15]. In line
with our results their study showed that variability in ALT, GGT,
and BILIRB to be significantly heritable (35–61%). By contrast to
our results, showed that additive genetic effects account for up to
20% of the variation in albumin levels, they showed no genetic
effect for ALB.
A larger study by Whitfield et al. [24] based on twins from the
Australian Twin Registry investigated the basis of variation and
covariation in three of the LFT proteins including GGT, ALT and
AST. In line with our results, Whitfield et al. showed that after
correcting for the effects of sex and age, GGT, ALT and AST
were highly heritable with additive genetic effects accounting for
52%, 48% and 32% of the variation in GGT, ALT and AST
respectively. Moreover, half of the genetic variance in GGT was
shown to be shared with ALT, AST, or both highlighting the
significant role of pleiotropy in the case of variation in the LFTs.
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PLoS ONE | www.plosone.org 4 February 2009 | Volume 4 | Issue 2 | e4435Although a thorough examination of the basis of covariation
between all the LFT proteins studied is beyond the scope of this
paper we did observe a high and significant phenotypic correlation
between GGT & ALT (r
2=0.5, p,1610
25) as well as ALT and
AST (r
2=0.29, p,1610
25) although GGT and AST levels were
not correlated (r
2=20.01, p=0.78).
A major, previously unreported finding in our study is the strong
influence of common environmental factors underpinning varia-
tion in the LFTs. Our result showed that variation in all but one of
the LFT proteins (GGT) are strongly influenced by common
environmental factors. In fact, in most cases the effect of common
environment is either comparable or larger than the heritability of
the trait. Although commonly highlighted as a strong motivation
for undertaking a twin rather than a family based study, common
environmental factors are seldom reported together with genetic
factors in the same study. This is in large part due to lack of power
in most twin studies to dissect the total familial component into its
sub-components of genetic and common environments [25,26].
Ignoring batch effects (our assays were designed to minimize batch
effects), potential common environmental effects include stress,
diet, and exposure to toxins, pathogens, radiation and chemicals.
Although the relative contribution of these factors to variation in
the LFTs would be purely speculative, one could argue that these
factors along with other myriad factors could have a significant
effect on an organ such as the liver which primarily functions as a
site of metabolism, storage, decomposition, synthesis and detox-
ification. The observed strong influence of common environmen-
tal factors needs to be confirmed in a study with such
environmental factors explicitly measured.
Although our study represents the largest and most extensive
genetic epidemiological study of the LFT protein, there are a few
potential limitations, which warrant further discussion. First, our
study was conducted in twins, which have been previously shown
to be representative of population-based samples for a wide range
of common medical conditions and lifestyle characteristics [27].
Therefore, the conclusion derived from our study in twin
population should be generalisable to the general population.
Second, although all the participant twins were deemed
generally healthy – i.e. not suffering from any chronic diseases
or taking prescribed medication - our results may have been
influenced to an extent by unforeseen perturbations due to an
infection, early stages of a disease, or a short course of an over the
counter medication or dietary supplement [1]. Moreover,
measurement errors, visit effects can all bias our results by
Table 4. Genetic model fitting results for variation in liver function test proteins.
Protein X
2 Df DX
2 DDf P Model A (95% C.I.) C (95% C.I.) E (95% C.I.)
ALT 7.73 3 – – 0.052 ACE 0.32 (0.19–0.44) 0.30 (0.21–0.34) 0.38 (0.34–0.44)
44.44 4 36.71 1 0.000 AE 0.66 (0.62–0.70) – 0.34(0.30–0.38)
29.71 4 21.98 1 0.000 CE – 0.50(0.46–0.53) 0.50(0.47–0.54)
ALB 6.38 3 – – 0.095 ACE 0.20 (0.06–0.32) 0.36 (0.26–0.45) 0.44 (0.39–0.50)
55.35 4 48.97 1 0.000 AE 0.62(0.58–0.66) – 0.38(0.34–0.42)
14.11 4 41.24 1 0.007 CE – 0.48(0.44–0.52) 0.52(0.48–0.55)
GGT 8.53 3 – – 0.036 ACE 0.69(0.58–0.78) 0.07(0.00–0.16) 0.24(0.21–0.27)
10.90 4 2.37 1 0.124 AE 0.77(0.74–0.80) – 0.23(0.20–0.26)
128.03 4 119.50 1 0.000 CE – 0.50(0.47–0.54) 0.50(0.46–0.53)
BILIRB 8.05 3 – – 0.045 ACE 0.46 (0.37–0.56) 0.28 (0.20–0.36) 0.26 (0.23–0.29)
45.83 4 37.78 1 0.000 AE 0.76(0.73–0.79) – 0.24(0.21–0.27)
81.81 4 73.75 1 0.000 CE – 0.58(0.55–0.61) 0.42(0.39–0.45)
TPROT 23.18 3 – – 0.000 ACE 0.15(0.00–0.26) 0.44(0.33–0.51) 0.41(0.35–0.46)
100.69 4 77.51 1 0.000 AE 0.67(0.63–0.70) – 0.33(0.30–0.37)
30.22 4 7.04 1 0.008 CE – 0.53(0.50–0.54) 0.47(0.44–0.50)
TGLOB 16.67 3 – – 0.001 ACE 0.26 (0.17–0.35) 0.48 (0.48–0.54) 0.26 (0.23–0.30)
148.28 4 131.60 1 0.000 AE 0.77(0.75–0.80) – 0.23(0.20–0.25)
45.61 4 28.94 1 0.000 CE – 0.64(0.62–0.67) 0.36(0.33–0.38)
AST 4.82 3 – – 0.185 ACE 0.40 (0.04–0.68) 0.34 (0.11–0.57) 0.26 (0.16–0.43)
12.92 4 8.10 1 0.004 AE 0.78(0.69–0.85) – 0.21(0.15–0.31)
9.31 4 4.49 1 0.034 CE – 0.57(0.48–0.65) 0.43(0.35–0.52)
ALP 1.37 3 – – 0.714 ACE 0.48 (0.38–0.58) 0.24 (0.15–0.32) 0.28 (0.25–0.32)
27.16 4 25.78 1 0.000 AE 0.74(0.71–0.77) – 0.26(0.23–0.29)
69.07 4 67.7 1 0.000 CE – 0.55(0.51–0.58) 0.45(0.42–0.49)
The best fitting model is highlighted in grey. For each protein, full models (ACE & ADE) was compared to nested models (AE, CE, E) using a chi-squared test DX
2=(X
2 sub
model)2(X
2 full model) with the degrees of freedom equal to DDf=(Df sub model)2(Df full model). The degrees of freedom increases from the full to sub or nested
models due to drop in the numbers of parameters estimated as one moves down the model hierarchy. To be judged a good-fit, models should have a non-significant
chi-squared goodness-of-fit statistic (p.0.05). Note, C and D cannot be included together in the same model as in quantitative genetic studies of human populations
they are confounded thus the full model is either ACE or ADE. Comparisons with the ACE full model are shown here. In all cases, ACE provided a better model fit than
ADE with a smaller chi-squared goodness-of-fit statistic (data not shown).
Abbreviations: X
2=chi-squared goodness-of-fit statistic; Df=degrees of freedom; DDf=(df sub model)2(df full model); D X
2=(X
2 sub model)2(X
2 full model); P=P-
Value; A=Additive genetic influence; C=Shared environmental variance; E=Unique environmental variance.
doi:10.1371/journal.pone.0004435.t004
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the LFT measurements even though care was taken to minimize
the effects of these factors by using randomization of the samples
prior to all biochemical analyses.
Third, due to non-technical reasons AST was only measured in
a sub-sample of the female twin cohort (98MZ & 477DZ) and not
in males at all. We are currently looking into increasing our sample
size in the case of AST for future genetic association studies.
Fourth, due to historical reasons the TwinsUK database is
predominantly female cohort and so we only had access to a
limited number of male samples (no more than 500 twins).
Fifth, although not a major component of our study, the quality
of data on alcohol consumption was not optimal. First, it was
‘‘recall’’ data collected from self-reported questionnaires and
second our alcohol data is not representative of the drinking status
of the individuals at the time at which the blood samples were
taken for biochemical assays of the LFTs. For example, previously
it has been reported that the amount of alcohol consumed in the
past 30 days is an important indicator of high levels of GGT [23].
In our study, the time at which self-reported data on alcohol use
was collected and the time at which blood samples were taken
were up to 3 years apart. Both of these factors could reduce any
association between alcohol consumption and the LFT proteins
including GGT.
Finally, our conclusions are restricted to Northern European
Caucasian populations and the results need to be replicated in
other independent cohorts of different ancestry.
In conclusion, our study suggests the presence of sex differences
and effect of age, BMI and alcohol consumption in variation of
liver function proteins among individuals. Substantial heritability
was observed for all the LFTs with the quantitative genetic
modeling showing that a great proportion of the variation in liver
function proteins are due to additive genetic effects stimulating
further research to identify the responsible genes/region. Identi-
fying the genes that influence the widely used liver function test
will be very important in the future interpretation of their results
and possibly reduce the need to further investigate subjects with
high levels due to normal genetic variation.
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